<DOC>
	<DOC>NCT02676830</DOC>
	<brief_summary>The purpose of this study is to Evaluation of absorption, metabolism, and excretion of [14C]-K-312 and estimation of the absolute bioavailability of K-312 in healthy male subjects</brief_summary>
	<brief_title>Evaluation of Absorption, Metabolism, and Excretion and Estimation of the Absolute Bioavailability of K-312</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>Subject provides written informed consent before any studyspecific evaluation is performed. Subject is a healthy adult male between the ages of 25 and 45 years, inclusive. Subject has a body mass index (BMI) of 18.5 to 30 kg/m2, inclusive. Presence of active or recurring clinically significant cardiovascular, pulmonary, renal, endocrine, hepatic, neurologic, psychiatric, immunologic, hematologic, gastrointestinal, or metabolic disease requiring medical treatment. Any surgical or medical condition that might significantly alter the absorption, distribution, metabolism, or excretion of K312. Clinically relevant abnormalities in clinical laboratory parameters, as judged by the Investigator.</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>